Related Experiment Video
Updated: Jul 12, 2025

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Intronic Germline DICER1 Variants in Patients With Sertoli-Leydig Cell Tumor
Claudette R Fraire1, Paige R Mallinger2,3,4, Jessica N Hatton5
1Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX.
Germline DICER1 pathogenic loss-of-function variants predispose individuals to cancers like Sertoli-Leydig cell tumors (SLCT). Novel intronic variants affecting splicing were identified in SLCT patients lacking typical DICER1 variants, suggesting broader diagnostic approaches.
Area of Science:
- Genetics and Oncology
- Molecular Biology
- Cancer Predisposition Syndromes
Background:
- Germline pathogenic loss-of-function (pLOF) variants in DICER1 are linked to various solid neoplasms, including Sertoli-Leydig cell tumors (SLCT).
- Common DICER1 pLOF variants include frameshift indels and nonsense or splice-site altering base substitutions.
- Some patients with DICER1-associated tumors lack detectable germline or tumor pLOF variants.
Purpose of the Study:
- To investigate the genetic basis of SLCT in patients without detectable germline DICER1 pLOF variants.
- To identify novel DICER1 variants that may contribute to tumorigenesis.
- To evaluate the utility of intronic variant and splicing analysis in diagnosing DICER1-related cancers.
Main Methods:
- Tumor sequencing was performed on two patients with SLCT.
- Conventional exon-directed germline sequencing was conducted.
- A custom capture panel was used for comprehensive DICER1 variant analysis, including intronic regions.
- Splicing analysis was performed to assess the functional impact of identified variants.
Main Results:
- Two patients with SLCT harbored only somatic missense DICER1 RNase IIIb variants in their tumors.
- No exonic pLOF variants were detected in the germline of these patients via conventional sequencing.
- Novel intronic variants (c.1752+213A>G and c.1509+16A>G) affecting DICER1 splicing were identified using a custom capture panel.
Conclusions:
- Somatic missense DICER1 variants and novel intronic variants impacting splicing can contribute to SLCT development.
- Conventional germline sequencing may miss pathogenic DICER1 variants in patients with DICER1-associated tumors.
- Intron sequencing and splicing analysis are recommended when no exonic DICER1 pLOF variants are found despite strong clinical suspicion for DICER1-related cancers.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Non-LTR Retrotransposons
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

